Ken Griffin Zimmer Biomet Holdings, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 132,600 shares of ZBH stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,600

Previous 111,400 19.03%

Holding current value

$14 Million

Previous $12.1 Million 18.38%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$104.47 - $116.17 $11.3 Million - $12.6 Million	108,295 Added 28.76%	484,778 $52.3 Million
Q2 2024 Aug 14, 2024	SELL	$106.25 - $130.01 $37.1 Million - $45.4 Million	-348,834 Reduced 48.09%	376,483 $40.9 Million
Q1 2024 May 15, 2024	BUY	$119.98 - $132.61 $14.6 Million - $16.1 Million	121,769 Added 20.18%	725,317 $95.7 Million
Q4 2023 Feb 14, 2024	SELL	$102.72 - $121.7 $94.3 Million - $112 Million	-918,153 Reduced 60.34%	603,548 $73.5 Million
Q3 2023 Nov 14, 2023	BUY	$110.76 - $143.18 $161 Million - $208 Million	1,455,618 Added 2202.71%	1,521,701 $171 Million
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $7.93 Million - $9.14 Million	62,759 Added 1888.06%	66,083 $9.62 Million
Q1 2023 May 15, 2023	SELL	$121.91 - $130.94 $284 Million - $305 Million	-2,328,300 Reduced 99.86%	3,324 $429,000
Q4 2022 Feb 14, 2023	BUY	$104.7 - $128.4 $13.6 Million - $16.7 Million	129,819 Added 5.9%	2,331,624 $297 Million
Q3 2022 Nov 14, 2022	BUY	$101.65 - $119.27 $219 Million - $258 Million	2,159,222 Added 5070.62%	2,201,805 $230 Million
Q2 2022 Aug 15, 2022	SELL	$102.23 - $133.85 $6.29 Million - $8.24 Million	-61,572 Reduced 59.12%	42,583 $4.47 Million
Q4 2021 Feb 14, 2022	SELL	$115.43 - $146.63 $43.5 Million - $55.2 Million	-376,755 Reduced 78.34%	104,155 $12.8 Million
Q3 2021 Nov 15, 2021	BUY	$136.35 - $158.76 $63.2 Million - $73.6 Million	463,388 Added 2644.61%	480,910 $70.4 Million
Q2 2021 Aug 16, 2021	SELL	$152.95 - $173.41 $190 Million - $216 Million	-1,245,020 Reduced 98.61%	17,522 $2.74 Million
Q1 2021 May 17, 2021	SELL	$148.16 - $159.71 $52 Million - $56.1 Million	-351,284 Reduced 21.77%	1,262,542 $202 Million
Q4 2020 Feb 16, 2021	BUY	$128.25 - $151.41 $108 Million - $128 Million	842,291 Added 109.17%	1,613,826 $249 Million
Q3 2020 Nov 16, 2020	SELL	$113.59 - $141.68 $8.18 Million - $10.2 Million	-72,028 Reduced 8.54%	771,535 $105 Million
Q2 2020 Aug 14, 2020	BUY	$87.02 - $133.4 $70 Million - $107 Million	803,960 Added 2030.05%	843,563 $101 Million
Q1 2020 May 15, 2020	SELL	$78.28 - $155.73 $15.6 Million - $31.1 Million	-199,572 Reduced 83.44%	39,603 $4 Million
Q4 2019 Feb 14, 2020	SELL	$127.4 - $146.83 $86.8 Million - $100 Million	-681,693 Reduced 74.03%	239,175 $35.8 Million
Q3 2019 Nov 14, 2019	BUY	$113.33 - $138.46 $52 Million - $63.6 Million	459,073 Added 99.41%	920,868 $123 Million
Q2 2019 Aug 14, 2019	SELL	$108.87 - $125.09 $124 Million - $142 Million	-1,138,796 Reduced 71.15%	461,795 $54.4 Million
Q1 2019 May 15, 2019	BUY	$97.5 - $125.79 $156 Million - $201 Million	1,597,107 Added 45841.19%	1,600,591 $0
Q4 2018 Feb 14, 2019	SELL	$94.4 - $126.76 $19.8 Million - $26.6 Million	-209,844 Reduced 98.37%	3,484 $350,000
Q3 2018 Nov 13, 2018	BUY	$108.41 - $127.64 $22.2 Million - $26.1 Million	204,695 Added 2371.08%	213,328 $0
Q1 2018 May 11, 2018	SELL	$104.31 - $124.46 $7.39 Million - $8.82 Million	-70,847 Reduced 89.14%	8,633 $941,000
Q4 2017 Feb 09, 2018	SELL	$105.55 - $120.83 $25.4 Million - $29 Million	-240,208 Reduced 75.14%	79,480 $9.59 Million
Q3 2017 Nov 09, 2017	BUY	$106.92 - $117.79 $34.2 Million - $37.7 Million	319,688	319,688 $37.4 Million

Others Institutions Holding ZBH

# of Institutions

1,079

Shares Held

178M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account